Helix BioPharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Sep '25 Sep 9, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021	Jul '20 Jul 31, 2020	2016 - 2020
Market Capitalization	111	56	42	33	117	72	Upgrade
Market Cap Growth	0.84%	34.21%	28.68%	-72.14%	63.19%	15.25%	Upgrade
Enterprise Value	110	56	41	34	115	66	Upgrade
Last Close Price	1.45	1.15	1.05	0.95	4.15	2.70	Upgrade
PB Ratio	-79.67	-626.39	-49.71	102.32	-84.09	24.08	Upgrade
P/TBV Ratio	-	-	-	102.32	-	29.99	Upgrade
Debt / Equity Ratio	-	-	-	7.74	-2.59	0.05	Upgrade
Quick Ratio	0.31	0.72	0.46	1.03	1.01	2.29	Upgrade
Current Ratio	0.42	0.92	0.53	1.08	1.04	2.42	Upgrade
Return on Equity (ROE)	-	-	-	-	-1205.79%	-	Upgrade
Return on Assets (ROA)	-562.96%	-458.65%	-166.12%	-96.84%	-127.23%	-184.23%	Upgrade
Return on Capital (ROIC)	-	-	-407.18%	-150.82%	-212.98%	-	Upgrade
Earnings Yield	-8.61%	-16.43%	-14.97%	-20.11%	-6.86%	-12.52%	Upgrade
FCF Yield	-3.55%	-9.28%	-13.18%	-19.94%	-7.94%	-15.10%	Upgrade
Buyback Yield / Dilution	-23.16%	-15.11%	-29.26%	-8.41%	-7.97%	-19.75%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.